Pioglitazone, a PPAR-γ Activator, Stimulates BK but Suppresses IK in Hippocampal Neurons

about

Pioglitazone, a PPAR-γ Activator, Stimulates BK but Suppresses IK in Hippocampal Neurons

Item

http://www.wikidata.org/entity/Q58694208

description

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Pioglitazone, a PPAR-γ Activator, Stimulates BK but Suppresses IK in Hippocampal Neurons

@en

Pioglitazone, a PPAR-γ Activator, Stimulates BK but Suppresses IK in Hippocampal Neurons

@nl

type

Item

label

Pioglitazone, a PPAR-γ Activator, Stimulates BK but Suppresses IK in Hippocampal Neurons

@en

Pioglitazone, a PPAR-γ Activator, Stimulates BK but Suppresses IK in Hippocampal Neurons

@nl

prefLabel

Pioglitazone, a PPAR-γ Activator, Stimulates BK but Suppresses IK in Hippocampal Neurons

@en

Pioglitazone, a PPAR-γ Activator, Stimulates BK but Suppresses IK in Hippocampal Neurons

@nl

P1476

Pioglitazone, a PPAR-γ Activator, Stimulates BK but Suppresses IK in Hippocampal Neurons

@en

P2093

Chin-Wei Huang

http://www.w3.org/2001/XMLSchema#string

Kao-Min Lin

http://www.w3.org/2001/XMLSchema#string

Ming-Chi Lai

http://www.w3.org/2001/XMLSchema#string

Sheng-Nan Wu

http://www.w3.org/2001/XMLSchema#string

Te-Yu Hung

http://www.w3.org/2001/XMLSchema#string

Tsang-Shan Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Two types of K(+) channel subunit, Erg1 and KCNQ2/3, contribute to the M-like current in a mammalian neuronal cell

Fat and beyond: the diverse biology of PPARgamma

Effects of long-term pioglitazone treatment on peripheral and central markers of aging.

Roles of PPARs in health and disease.

Modulation and genetic identification of the M channel.

Pioglitazone improves potassium channel remodeling induced by angiotensin II in atrial myocytes.

Ability of naringenin, a bioflavonoid, to activate M-type potassium current in motor neuron-like cells and to increase BKCa-channel activity in HEK293T cells transfected with α-hSlo subunit.

The pharmacokinetics of pioglitazone in patients with impaired renal function.

Characterisation of Signalling by the Endogenous GPER1 (GPR30) Receptor in an Embryonic Mouse Hippocampal Cell Line (mHippoE-18).

Evidence for inhibitory effects of flupirtine, a centrally acting analgesic, on delayed rectifier k(+) currents in motor neuron-like cells.

P304

977

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHAR.2018.00977

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30210346

http://www.w3.org/2001/XMLSchema#string

P921

Farmakologi

P932

6123368

http://www.w3.org/2001/XMLSchema#string